Aside from being a treatment with long-term effectiveness, allergy immunotherapy has other benefits according to the American Academy of Allergy, Asthma & Immunology (AAAAI)

The approach is the “only available treatment for allergic rhinitis that is potentially curative and may prevent the progression from allergic rhinitis to asthma,” said Dr Linda Cox, MD, President and Fellow of the AAAAI. “Gaining FDA-approved forms of sublingual immunotherapy will be huge in terms of treatment options for patients.”

The Agency for Healthcare Research and Quality recently published a review declaring allergy immunotherapy safe and effective for treating nasal allergies and mild asthma in adults and children.